Details for Patent: 7,989,494

Which drugs does patent 7,989,494 protect, and when does it expire?

Patent 7,989,494 protects FARYDAK and is included in one NDA.

This patent has forty-four patent family members in thirty-one countries.

Summary for Patent: 7,989,494

Title:	Polymorphs of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide
Abstract:	Polymorphic forms of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide free base and salts thereof are prepared by various processes.
Inventor(s):	Murat Acemoglu, Joginder S. Bajwa, Piotr Karpinski, Dimitris Papoutsakis, Joel Slade, Frank Stowasser
Assignee:	Pharma and Schweiz GmbH
Application Number:	US12/302,564
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,989,494
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 7,989,494

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Secura	FARYDAK	panobinostat lactate	CAPSULE;ORAL	205353-001	Feb 23, 2015		DISCN	Yes	No			Y	Y
Secura	FARYDAK	panobinostat lactate	CAPSULE;ORAL	205353-002	Feb 23, 2015		DISCN	Yes	No			Y	Y
Secura	FARYDAK	panobinostat lactate	CAPSULE;ORAL	205353-003	Feb 23, 2015		DISCN	Yes	No			Y	Y

Foreign Priority and PCT Information for Patent: 7,989,494

PCT Information
PCT Filed	June 07, 2007	PCT Application Number:	PCT/US2007/070561
PCT Publication Date:	December 21, 2007	PCT Publication Number:	WO2007/146716

International Family Members for US Patent 7,989,494

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	061297
Australia	2007257881
Brazil	PI0712993
Canada	2650263
Chile	2007001689
China	101641328